APA (7th ed.) Citation

Khattak, S., Ochoa-Ferraro, A., Khan, N., George, S., Khan, S. Q., Townend, J. N., . . . Thomas, M. R. (2025). Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia. Journal of Clinical Medicine, 14(22), 7946. https://doi.org/10.3390/jcm14227946

Chicago Style (17th ed.) Citation

Khattak, Sophia, Antonio Ochoa-Ferraro, Nazish Khan, Sudhakar George, Sohail Q. Khan, Jonathan N. Townend, Charlotte Dawson, and Mark R. Thomas. "Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia." Journal of Clinical Medicine 14, no. 22 (2025): 7946. https://doi.org/10.3390/jcm14227946.

MLA (9th ed.) Citation

Khattak, Sophia, et al. "Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia." Journal of Clinical Medicine, vol. 14, no. 22, 2025, p. 7946, https://doi.org/10.3390/jcm14227946.